fig1

Plexiform neurofibromas in neurofibromatosis type 1: current and emergent therapeutic strategies

Figure 1. Mechanism of MEK inhibition by selumetinib and mirdametinib. Loss of NF1 function leads to overactive Ras signaling, promoting tumor growth. Created in BioRender. Kim, H. (2025) https://BioRender.com/796ondy. NF1: Neurofibromatosis type 1; MEK 1/2: mitogen-activated protein kinase kinase; ERK: extracellular signal-regulated kinase.